Furthermore, we confirmed that IL-17 deficiency could disturb the gut microbiota composition in MCD diet-fed mice, as indicated by the increased abundance of pathogenic bacteria and decreased probiotics, exacerbating hepatic steatosis accumulation and promoting NAFLD/NASH progression. Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.